Want to join the conversation?
George Tong of Piper Jaffray asks about potential cost to synergies arising from the split. $XRX CEO Ursula Burns said the company is going to try to hold that conversation until the middle of the year when there is a better grasp on what they are specifically. Some of the general to synergies are called independent company cost to synergies.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?